Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. A Radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Nuclear Medicine/Radiopharmaceutic industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Diagnostic
Therapeutic
Market Segment by Product Application
Oncology
Thyroid
Cardiology
Finally, the report provides detailed profile and data information analysis of leading company.
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Nuclear Medicine/Radiopharmaceutic consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Nuclear Medicine/Radiopharmaceutic market by identifying its various subsegments.
3.Focuses on the key global Nuclear Medicine/Radiopharmaceutic manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Nuclear Medicine/Radiopharmaceutic with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Nuclear Medicine/Radiopharmaceutic submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Nuclear Medicine/Radiopharmaceutic Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Nuclear Medicine/Radiopharmaceutic Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Nuclear Medicine/Radiopharmaceutic Segment by Type
2.1.1 Diagnostic
2.1.2 Therapeutic
2.2 Market Analysis by Application
2.2.1 Oncology
2.2.2 Thyroid
2.2.3 Cardiology
2.3 Global Nuclear Medicine/Radiopharmaceutic Market Comparison by Regions (2017-2027)
2.3.1 Global Nuclear Medicine/Radiopharmaceutic Market Size (2017-2027)
2.3.2 North America Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.3.3 Europe Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.3.4 China Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.3.5 Japan Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.3.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine/Radiopharmaceutic Industry Impact
2.5.1 Nuclear Medicine/Radiopharmaceutic Business Impact Assessment - Covid-19
2.5.2 Market Trends and Nuclear Medicine/Radiopharmaceutic Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Nuclear Medicine/Radiopharmaceutic Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share
3.5 Top 10 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
3.7 Key Manufacturers Nuclear Medicine/Radiopharmaceutic Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Nuclear Medicine/Radiopharmaceutic Industry Key Manufacturers
4.1 China Isotope & Radiation
4.1.1 Compan Detail
4.1.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.1.3 China Isotope & Radiation 139 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 China Isotope & Radiation News
4.2 Dongcheng
4.2.1 Compan Detail
4.2.2 Dongcheng Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.2.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 China Isotope & Radiation News
4.3 Jaco
4.3.1 Compan Detail
4.3.2 Jaco Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.3.3 Jaco Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Jaco News
4.4 Ciaeriar
4.4.1 Compan Detail
4.4.2 Ciaeriar Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Ciaeriar News
4.5 Advanced Molecular-imaging Solution
4.5.1 Compan Detail
4.5.2 Ciaeriar Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Advanced Molecular-imaging Solution News
4.6 Shanghai Atom Kexing
4.6.1 Compan Detail
4.6.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification
4.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Shanghai Atom Kexing News
5 Global Nuclear Medicine/Radiopharmaceutic Market Segment by Big Type
5.1 Global Nuclear Medicine/Radiopharmaceutic Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Big Type (2017-2022)
5.2 Diagnostic Sales Growth Rate and Price
5.2.1 Global Diagnostic Sales Growth Rate (2017-2022)
5.2.2 Global Diagnostic Price (2017-2022)
5.3 Therapeutic Sales Growth Rate and Price
5.3.1 Global Therapeutic Sales Growth Rate (2017-2022)
5.3.2 Global Therapeutic Price (2017-2022)
6 Global Nuclear Medicine/Radiopharmaceutic Market Segment by Big Application
6.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Big Application (2017-2022)
6.2 Oncology Sales Growth Rate (2017-2022)
6.3 Thyroid Sales Growth Rate (2017-2022)
6.4 Cardiology Sales Growth Rate (2017-2022)
7 Global Nuclear Medicine/Radiopharmaceutic Forecast
7.1 Global Nuclear Medicine/Radiopharmaceutic Revenue, Sales and Growth Rate (2022-2027)
7.2 Nuclear Medicine/Radiopharmaceutic Market Forecast by Regions (2022-2027)
7.2.1 North America Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
7.2.2 Europe Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
7.2.3 China Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
7.2.4 Japan Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
7.2.5 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
7.2.6 Other Regions Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
7.3 Nuclear Medicine/Radiopharmaceutic Market Forecast by Type (2022-2027)
7.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2022-2027)
7.3.2 Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Type (2022-2027)
7.4 Nuclear Medicine/Radiopharmaceutic Market Forecast by Application (2022-2027)
7.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2022-2027)
7.4.2 Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Nuclear Medicine/Radiopharmaceutic Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Nuclear Medicine/Radiopharmaceutic
Figure Market Concentration Ratio and Market Maturity Analysis of Nuclear Medicine/Radiopharmaceutic
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Nuclear Medicine/Radiopharmaceutic Market Size by Big Type
Figure Global Market Share of Nuclear Medicine/Radiopharmaceutic by Big Type in 2021
Figure Diagnostic Picture (2017-2022)
Global Nuclear Medicine/Radiopharmaceutic Market Size by Big Application
Table Global Nuclear Medicine/Radiopharmaceutic Market Size by Application
Figure Global Nuclear Medicine/Radiopharmaceutic Market Share by Big Application in 2021
Figure Oncology Picture
Figure Thyroid Picture
Figure Cardiology Picture
Table Global Nuclear Medicine/Radiopharmaceutic Comparison by Regions (M USD) (2017-2027?
Figure Global Nuclear Medicine/Radiopharmaceutic Market Size (Million US$) (2017-2027)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Nuclear Medicine/Radiopharmaceutic Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturer (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturer in 2021
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturer (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Manufacturer in 2021
Table Global Nuclear Medicine/Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Nuclear Medicine/Radiopharmaceutic Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Nuclear Medicine/Radiopharmaceutic Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table Mergers & Acquisitions Planning
Table China Isotope & Radiation Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of China Isotope & Radiation
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Dongcheng Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Dongcheng
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dongcheng Recent Development
Table Jaco Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Jaco
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Jaco Main Business
Table Jaco Recent Development
Table Ciaeriar Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Ciaeriar
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ciaeriar Main Business
Table Ciaeriar Recent Development
Table Ciaeriar Main Business
Table Ciaeriar Recent Development
Table Advanced Molecular-imaging Solution Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Advanced Molecular-imaging Solution
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Advanced Molecular-imaging Solution Main Business
Table Advanced Molecular-imaging Solution Recent Development
Table Shanghai Atom Kexing Company Profile
Table Nuclear Medicine/Radiopharmaceutic Product Introduction, Application and Specification of Shanghai Atom Kexing
Table Nuclear Medicine/Radiopharmaceutic Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shanghai Atom Kexing Main Business
Table Shanghai Atom Kexing Recent Development
Figure Global Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Regions (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions in 2021
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions in 2021
Figure North America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure China Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Figure Other Regions Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Big Type (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Big Type (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Big Type in 2019
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Big Type (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Big Type (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Big Type in 2019
Figure Global Diagnostic Sales Growth Rate (2017-2022)
Figure Global Diagnostic Price (2017-2022)
Figure Global Therapeutic Sales Growth Rate (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Big Application (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Big Application (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Big Application in 2019
Figure Global Oncology Sales Growth Rate (2017-2022)
Figure Global Thyroid Sales Growth Rate (2017-2022)
Figure Global Cardiology Sales Growth Rate (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2022-2027)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Regions (2022-2027)
Figure North America Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Figure Europe Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Figure China Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Figure Japan Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Figure Southeast Asia Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Figure Other Regions Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Type (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2022-2027)
Table Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Nuclear Medicine/Radiopharmaceutic Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Nuclear Medicine/Radiopharmaceutic Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Nuclear Medicine/Radiopharmaceutic Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)